A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

← catalyst calendar

NCT07525791 · readout in 232 d

Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.

Phase

Phase 1

Status

Recruiting

Study type

Interventional

Design

Na · None · Treatment

Enrollment

45estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2026-04-07

actual

When the study began enrolling

Primary completion

2027-04-08

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2027-05-04

estimated

The whole study's end, after follow-up

First posted

2026-04-13

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-04-24

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Overweight
Obesity

Interventions

Drug: NNC0662-0419
Drug: Oral contraceptive
Drug: Acetaminophen

Primary outcomes

what the primary-completion date above is the date OF

Area under curve (AUC) 0-24 h, EE, steady state (SS): The area under the EE plasma concentration-time curve (pre-dose to 24 hours post-dose)

measured Day 8 and 1 day after last NNC0662-0419 dose

AUC0-24h, LN, SS: The area under the LN plasma concentration-time curve (pre-dose to 24 hours post-dose)

measured Day 8 and 1 day after last NNC0662-0419 dose

Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed